Clonidine Versus Tranexamic Acid in Reduction of Blood Loss

• Status: Recruiting
• Trial end date: 2022-08-03
• Target enrollment: 0
• Participant gender: Female

Summary

Tranexamic acid is an antifibrinolytics agent that has been widely used in the reduction of blood loss at surgeries. Oral clonidine is an alpha-2 adrenergic agonist that has been used in various surgeries including Caesarean section.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Uwakwe Emmanuel Chijioke
• Treatments: Clonidine

Criteria

Inclusion Criteria:

• Participants for the study include consenting parturients with singleton pregnancy at 37-42 weeks gestational age,admitted for elective caesarean section.

Exclusion Criteria:

• Prior history of thromboembolism or bleeding disorder

• Renal disease

• Liver disease

• Antepartum Hemorrhage

• Intrauterine Growth restricted fetuses

• Patient refusal